Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

361
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
361
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

335
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
335

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Desiderata for a biomedical knowledge network: opportunities, challenges and future directions.

Bioinformatics advances·2026
Same author

Federated knowledge retrieval elevates large language model performance on biomedical benchmarks.

GigaScience·2026
Same author

The NIAID Discovery Portal: a unified search engine for infectious and immune-mediated disease datasets.

mSystems·2025
Same author

Federated Knowledge Retrieval Elevates Large Language Model Performance on Biomedical Benchmarks.

bioRxiv : the preprint server for biology·2025
Same author

Announcing the Biomedical Data Translator: Initial Public Release.

Clinical and translational science·2025
Same author

Drug Repurposing using consilience of Knowledge Graph Completion methods.

bioRxiv : the preprint server for biology·2024

相关实验视频

Updated: Jan 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

一个基于案例的可解释图形神经网络框架,用于机械药物重新定位.

Adriana Carolina Gonzalez-Cavazos1, Roger Tu1, Meghamala Sinha1

  • 1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, CA 92037, United States.

Bioinformatics (Oxford, England)
|January 14, 2026
PubMed
概括

药物重新定位使用现有药物治疗新疾病. 一个新的可解释的图形神经网络模型,DBR-X,准确地预测了药物疾病联系,并提供了可解释的生物机制.

科学领域:

  • 计算生物学 计算生物学
  • 药理学 药理学是指药理学的学科.
  • 人工智能的人工智能

背景情况:

  • 药物重新定位通过将现有药物重新用于新的治疗用途来加速药物发现.
  • 图形神经网络 (GNN) 显示出预测药物疾病关联的潜力,但往往缺乏可解释性.
  • 可解释性对于验证预测和了解药物作用的生物机制至关重要.

研究的目的:

  • 引入基于药物的推理解释器 (DBR-X),用于药物重新定位的可解释的GNN模型.
  • 增强基于GNN的药物疾病关联预测的可解释性和可信度.
  • 为已识别的关联提供多环生物解释,以帮助临床翻译.

主要方法:

  • 开发了DBR-X,这是一个可解释的GNN模型,集成了链接预测和路径识别模块.
  • 将DBR-X与现有的GNN链接预测框架进行基准测试,以确定药物疾病关联的准确性.
  • 使用策划机制,忠实性研究 (删除/插入) 和稳定性分析评估解释的生物质量.

主要成果:

  • 与其他GNN框架相比,DBR-X在预测已知的药物疾病关联方面表现优异.
  • 在识别药物疾病联系时,在所有评估指标中实现了更高的准确性.
  • 由DBR-X生成的生物学解释通过多种严格的评估方法得到了验证.

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

627
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

相关实验视频

Last Updated: Jan 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

627
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

结论:

  • DBR-X通过提供准确和可解释的预测,推进了基于GNN的药物重新定位的最新技术.
  • 该模型生成多跳解释的能力可以加速计算药物发现的临床应用.
  • DBR-X为了解药物机制并促进新疗法的开发提供了有价值的工具.